These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 13037663)

  • 1. Prevention of the androgenic effects of testosterone propionate by ali-esterase inhibition.
    MYERS DK; SIMONS SP
    Biochem J; 1953 Feb; 53(3):xvii. PubMed ID: 13037663
    [No Abstract]   [Full Text] [Related]  

  • 2. Androgenic hormones and ali-esterase inhibition.
    MYERS DK; SIMONS SP; ERICA SP; SIMONS GL
    Biochem J; 1953 Jun; 55(319th Meeting):i-ii. PubMed ID: 13093641
    [No Abstract]   [Full Text] [Related]  

  • 3. Ali-esterase inhibition by tri-ortho-cresyl phosphate.
    MENDEL B; MYERS DK
    Biochem J; 1953 Feb; 53(3):xvi. PubMed ID: 13037662
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of inhibition and activation of ali-esterase on the acute toxicity of organophosphates in rats].
    Jokanović M
    God Vojnomed Akad; 1986; 28():60-3. PubMed ID: 3482061
    [No Abstract]   [Full Text] [Related]  

  • 5. Tricresyl phosphates and cholinesterase.
    ALDRIDGE WN
    Biochem J; 1954 Feb; 56(2):185-9. PubMed ID: 13140171
    [No Abstract]   [Full Text] [Related]  

  • 6. Tocopherol deficiency produced by tri-o-cresyl phosphate.
    MYERS DK; MULDER HE; SIMONS EG
    Biochem J; 1953 Jun; 55(319th Meeting):i. PubMed ID: 13093640
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of tri-ortho-cresyl phosphate on the absorption of tocopherol.
    MEYERS DK; MULDER HE
    Nature; 1953 Oct; 172(4382):773. PubMed ID: 13111188
    [No Abstract]   [Full Text] [Related]  

  • 8. Observations on the specificity of the inhibition of cholinesterases by tri-orthocresyl phosphate.
    EARL CJ; THOMPSON RH; WEBSTER GR
    Br J Pharmacol Chemother; 1953 Mar; 8(1):110-4. PubMed ID: 13066705
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of the cholinesterase of the central nervous system by organophosphorus compounds.
    DAVISON AN
    Biochem J; 1953 Jun; 54(3):xix-xx. PubMed ID: 13058939
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inhibitory activities of tri-ortho-cresyl phosphate (TOCP) against cholinesterase and neurotoxic esterase].
    Kawai M; Iyatomi A; Kaneko Y
    Sangyo Igaku; 1984 Jan; 26(1):68-9. PubMed ID: 6482069
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the androgenic activity of 9alpha-fluoro-11beta-hydroxy-17-methyltestosterone ('ultandren') II. A comparison between the androgenic properties of 'ultadren' and testosterone propionate.
    CLEGG EJ; FARLEY TM
    J Reprod Fertil; 1962 Oct; 4():131-6. PubMed ID: 14040704
    [No Abstract]   [Full Text] [Related]  

  • 12. POTENTIATION OF ANDROGENIC ACTION OF TESTOSTERONE PROPIONATE BY SODIUM MOLYBDATE.
    KAR AB; DAS RP; BANERJEE AK
    Ann Biochem Exp Med; 1963 Jan; 23():15-22. PubMed ID: 14060839
    [No Abstract]   [Full Text] [Related]  

  • 13. Potentiation of acrylate ester toxicity by prior treatment with the carboxylesterase inhibitor triorthotolyl phosphate (TOTP).
    Silver EH; Murphy SD
    Toxicol Appl Pharmacol; 1981 Feb; 57(2):208-19. PubMed ID: 7222037
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in serum alpha2u-globulin levels in castrated male rats treated with testosterone propionate in a Hershberger assay.
    Takeyoshi M; Mitoma H; Yamasaki K
    J Appl Toxicol; 2005; 25(2):176-8. PubMed ID: 15798992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgenic profile and genotoxicity evaluation of testosterone propionate and novel synthesized heterocyclic steroids.
    Hana HY; Khalil WK; Elmakawy AI; Elmegeed GA
    J Steroid Biochem Mol Biol; 2008 Jun; 110(3-5):284-94. PubMed ID: 18513952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the spermatogenic and androgenic properties of testosterone propionate with those of pituitary ICSH in hypophysectomized 40-day old male rats.
    SIMPSON ME; EVANS HM
    Endocrinology; 1946 Nov; 39(5):281-5. PubMed ID: 20276256
    [No Abstract]   [Full Text] [Related]  

  • 17. Testosterone phenyl propionate (TPP): biological trials with a new androgen.
    DEKANSKI J; CHAPMAN RN
    Br J Pharmacol Chemother; 1953 Sep; 8(3):271-7. PubMed ID: 13093945
    [No Abstract]   [Full Text] [Related]  

  • 18. [Renotropic action of testosterone propionate; studies on mice and rats kidneys following treatment with testosterone propionate].
    BALLERIO L
    Arch Ital Urol; 1951; 25(2):85-97. PubMed ID: 14915742
    [No Abstract]   [Full Text] [Related]  

  • 19. [Renotropic properties of testosterone propionate; testosterone propionate and experimental nephrosis produced by uranium nitrate in rats].
    BALLERIO L
    Arch Ital Urol; 1951; 25(2):145-58. PubMed ID: 14915745
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of methyl testosterone and testosterone propionate in premature infants.
    SHELTON EK; MARK JS
    J Clin Endocrinol Metab; 1947 Jun; 7(6):465. PubMed ID: 20344120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.